These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32427023)

  • 1. Ten-Year Trends in Enrollment of Women and Minorities in Pivotal Trials Supporting Recent US Food and Drug Administration Approval of Novel Cardiometabolic Drugs.
    Khan MS; Shahid I; Siddiqi TJ; Khan SU; Warraich HJ; Greene SJ; Butler J; Michos ED
    J Am Heart Assoc; 2020 Jun; 9(11):e015594. PubMed ID: 32427023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of the elderly, women, and minorities in pivotal trials supporting 2011-2013 U.S. Food and Drug Administration approvals.
    Downing NS; Shah ND; Neiman JH; Aminawung JA; Krumholz HM; Ross JS
    Trials; 2016 Apr; 17():199. PubMed ID: 27079511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015.
    Chen A; Wright H; Itana H; Elahi M; Igun A; Soon G; Pariser AR; Fadiran EO
    J Womens Health (Larchmt); 2018 Apr; 27(4):418-429. PubMed ID: 29048983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
    Allison K; Patel DG; Greene L
    JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020.
    Berkowitz ST; Groth SL; Gangaputra S; Patel S
    JAMA Ophthalmol; 2021 Jun; 139(6):629-637. PubMed ID: 33885724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms.
    Al Hadidi S; Schinke C; Thanendrarajan S; Zangari M; van Rhee F
    JAMA Netw Open; 2022 Apr; 5(4):e228161. PubMed ID: 35442451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review.
    Tahhan AS; Vaduganathan M; Greene SJ; Alrohaibani A; Raad M; Gafeer M; Mehran R; Fonarow GC; Douglas PS; Bhatt DL; Butler J
    JAMA Cardiol; 2020 Jun; 5(6):714-722. PubMed ID: 32211813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of Women in Clinical Trials Supporting FDA Approval of Cardiovascular Drugs.
    Scott PE; Unger EF; Jenkins MR; Southworth MR; McDowell TY; Geller RJ; Elahi M; Temple RJ; Woodcock J
    J Am Coll Cardiol; 2018 May; 71(18):1960-1969. PubMed ID: 29724348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race and Ethnicity Reporting and Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Breast Cancer Between 2010 and 2020.
    Nguyen RH; Silva Y; Lu J; Chen Z; Gadi V
    Clin Breast Cancer; 2023 Aug; 23(6):591-597. PubMed ID: 37296063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Representation of women in clinical trials supporting FDA-approval of contemporary cancer therapies.
    Kalathoor S; Ghazi S; Otieno B; Babcook MA; Chen S; Nidhi N; Bae J; Pierre-Charles J; Breathett K; Mazimba S; Johnson A; Brewer L; Mohammed S; Carter RR; Bonsu JM; Ferdousi M; Kola-Kehinde O; McLaughlin E; Brammer J; Ruz P; Khan S; Odei B; Mitchell D; Wei L; Patel P; Paskett ED; Addison D
    Int J Cancer; 2024 Dec; 155(11):1958-1968. PubMed ID: 39155749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the globalization of cancer clinical trials on the enrollment of Black patients.
    Tharakan S; Zhong X; Galsky MD
    Cancer; 2021 Jul; 127(13):2294-2301. PubMed ID: 33682111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of race/ethnicity in trials leading to anti-rheumatic drug approval for inflammatory arthritis by the US Food and Drug Administration.
    Xie Y; Liu Y; Qin Y; Chen X; Xie Q
    Int J Rheum Dis; 2023 Dec; 26(12):2489-2497. PubMed ID: 37854006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs.
    Fogacci F; Borghi C; Di Micoli A; Degli Esposti D; Cicero AFG
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3305-3313. PubMed ID: 34656384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals.
    Idris MY; Fitzsimmons WE; Pemu P
    Ther Innov Regul Sci; 2024 Jan; 58(1):175-183. PubMed ID: 37872439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic Disparities in the Federal Drug Approval Process for Allergic Rhinitis Medications.
    Liebowitz A; Spielman DB; Schlosser RJ; Stewart MG; Gudis DA
    Laryngoscope; 2023 Apr; 133(4):755-763. PubMed ID: 35394648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017.
    Zhang AD; Puthumana J; Downing NS; Shah ND; Krumholz HM; Ross JS
    JAMA Netw Open; 2020 Apr; 3(4):e203284. PubMed ID: 32315070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographics of clinical trials participants in pivotal clinical trials for new molecular entity drugs and biologics approved by FDA From 2010 to 2012.
    Eshera N; Itana H; Zhang L; Soon G; Fadiran EO
    Am J Ther; 2015; 22(6):435-55. PubMed ID: 25621972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the U.S. Food and Drug Administration : A Cross-Sectional Analysis.
    Awan FA; Becker AB; Wang Y; Kimmelman J
    Ann Intern Med; 2022 Dec; 175(12):1675-1684. PubMed ID: 36410007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.